CNBC 快讯 11月19日 09:57 诺华将旗舰药销售预期上调至180亿美元,寻求证明增长可持续性 Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis,… NVS XLV 医疗 FG 100 读报告 →